Insulin-like growth factor promotes cardiac lineage induction in vitro by selective expansion of early mesoderm.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 24496962.
- Also identified by DOI 10.1002/stem.1660 and PMC identifier 4037352.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
A thorough understanding of the developmental signals that direct pluripotent stem cells (PSCs) toward a cardiac fate is essential for translational applications in disease modeling and therapy. We screened a panel of 44 cytokines/signaling molecules for their ability to enhance Nkx2.5(+) cardiac progenitor cell (CPC) formation during in vitro embryonic stem cell (ESC) differentiation. Treatment of murine ESCs with insulin or insulin-like growth factors (IGF1/2) during early differentiation increased mesodermal cell proliferation and, consequently, CPC formation. Furthermore, we show that downstream mediators of IGF signaling (e.g., phospho-Akt and mTOR) are required for this effect. These data support a novel role for IGF family ligands to expand the developing mesoderm and promote cardiac differentiation. Insulin or IGF treatment could provide an effective strategy to increase the PSC-based generation of CPCs and cardiomyocytes for applications in regenerative medicine.
Medical subject headings
- Cell Lineage
- Insulin-Like Growth Factor I
- Insulin-Like Growth Factor II
- Mesoderm
- Myocardium